“Role of Dapagliflozin in the Management of Body Mass Index (BMI) and Glycated Hemoglobin (Hba1c) in Obese Type 2 Diabetic Patients”. 2023. Medical Forum Monthly 33 (12). http://medicalforummonthly.com/index.php/mfm/article/view/1453.